China National Accord Medicines (SZSE:000028) ROE % Adjusted to Book Value

: 10.25% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's ROE % for the quarter that ended in Dec. 2023 was 9.53%. China National Accord Medicines's PB Ratio for the quarter that ended in Dec. 2023 was 0.93. China National Accord Medicines's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 10.25%.

China National Accord Medicines ROE % Adjusted to Book Value Historical Data

The historical data trend for China National Accord Medicines's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

6.89

7.40

8.74

11.01

10.26

China National Accord Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value																12.68	7.72	7.75	8.23	10.25

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines ROE % Adjusted to Book Value Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's ROE % Adjusted to Book Value falls into.

China National Accord Medicines ROE % Adjusted to Book Value Calculation

China National Accord Medicines's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.54%	/	0.93
	=	10.26%

China National Accord Medicines's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.53%	/	0.93
	=	10.25%

China National Accord Medicines ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines